Valitor (Drug Discovery) Overview
- Year Founded
-
2010

- Status
-
Private
- Employees
-
15

- Latest Deal Type
-
University Spin-Out
- Investors
-
20
Valitor (Drug Discovery) General Information
Description
Developer of new generation drugs designed to improve the current treatment strategies for a variety of diseases. The company's drugs act within a targeted diseased tissue and modify therapeutic proteins to achieve substantial control over pharmacokinetics, enabling physicians to treat their patients in an enhanced way.
Contact Information
Website
www.valitorbio.comCorporate Office
- 2956 San Pablo Avenue
- Berkeley, CA 94702
- United States
Corporate Office
- 2956 San Pablo Avenue
- Berkeley, CA 94702
- United States
Valitor (Drug Discovery) Timeline
Valitor (Drug Discovery) Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
10. University Spin-Out | 01-Oct-2010 | Completed | Startup | |||
9. Secondary Transaction - Private | 03-Oct-2023 | Completed | Pre-Clinical Trials | |||
8. Accelerator/Incubator | 20-Sep-2023 | Completed | Pre-Clinical Trials | |||
7. Later Stage VC (Series B) | 05-Oct-2022 | Completed | Pre-Clinical Trials | |||
6. Grant | 01-Jul-2021 | Completed | Pre-Clinical Trials | |||
5. Seed Round | 21-Sep-2018 | Completed | Pre-Clinical Trials | |||
4. Grant | 01-Jan-2018 | Completed | Pre-Clinical Trials | |||
3. Accelerator/Incubator | 01-Feb-2018 | Completed | Pre-Clinical Trials | |||
2. Accelerator/Incubator | 28-Oct-2015 | $50K | $50K | Completed | Pre-Clinical Trials | |
1. Grant | 01-May-2014 | $2.12M | Completed | Pre-Clinical Trials |
Valitor (Drug Discovery) Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | ||||||||
Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Valitor (Drug Discovery) Comparisons
Industry
Financing
Details
Valitor (Drug Discovery) Competitors (2)
One of Valitor (Drug Discovery)’s 2 competitors is Monte Rosa Therapeutics, a Formerly VC-backed company based in Boston, MA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Monte Rosa Therapeutics | Formerly VC-backed | Boston, MA | ||||
Inhibrx | Formerly VC-backed | La Jolla, CA |
Valitor (Drug Discovery) Patents
Valitor (Drug Discovery) Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230406916-A1 | Humanized multivalent protein conjugates | Pending | 15-Apr-2022 | ||
US-20230405133-A1 | Purified multivalent protein-hyaluronic acid polymer conjugates | Pending | 15-Apr-2022 | ||
AU-2023254257-A1 | Humanized multivalent protein conjugates | Pending | 15-Apr-2022 | ||
AU-2023254113-A1 | Purified multivalent protein-hyaluronic acid polymer conjugates | Pending | 15-Apr-2022 | ||
AU-2023252928-A1 | Method of treating uveitis with multivalent protein-hyaluronic acid polymer conjugate | Pending | 15-Apr-2022 | C07K14/8114 |
Valitor (Drug Discovery) Signals
Valitor (Drug Discovery) Investors (20)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
5Y Capital | Venture Capital | Minority | ||
Angel Physicians Fund | Angel Group | Minority | ||
ExSight Ventures | Venture Capital | Minority | ||
First Spark Ventures | Venture Capital | Minority | ||
Morningside Group | Venture Capital | Minority |
Valitor (Drug Discovery) FAQs
-
When was Valitor (Drug Discovery) founded?
Valitor (Drug Discovery) was founded in 2010.
-
Where is Valitor (Drug Discovery) headquartered?
Valitor (Drug Discovery) is headquartered in Berkeley, CA.
-
What is the size of Valitor (Drug Discovery)?
Valitor (Drug Discovery) has 15 total employees.
-
What industry is Valitor (Drug Discovery) in?
Valitor (Drug Discovery)’s primary industry is Drug Discovery.
-
Is Valitor (Drug Discovery) a private or public company?
Valitor (Drug Discovery) is a Private company.
-
What is Valitor (Drug Discovery)’s current revenue?
The current revenue for Valitor (Drug Discovery) is
. -
How much funding has Valitor (Drug Discovery) raised over time?
Valitor (Drug Discovery) has raised $30.6M.
-
Who are Valitor (Drug Discovery)’s investors?
5Y Capital, Angel Physicians Fund, ExSight Ventures, First Spark Ventures, and Morningside Group are 5 of 20 investors who have invested in Valitor (Drug Discovery).
-
Who are Valitor (Drug Discovery)’s competitors?
Monte Rosa Therapeutics and Inhibrx are competitors of Valitor (Drug Discovery).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »